These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 17980236)

  • 1. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand.
    Balamongkhon B; Thamlikitkul V
    Am J Infect Control; 2007 Nov; 35(9):585-8. PubMed ID: 17980236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand.
    Maenthaisong R; Chaiyakunapruk N; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S94-101. PubMed ID: 17718250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine.
    Chaiyakunapruk N; Veenstra DL; Lipsky BA; Sullivan SD; Saint S
    Clin Infect Dis; 2003 Sep; 37(6):764-71. PubMed ID: 12955636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
    Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
    Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison.
    Girard R; Comby C; Jacques D
    J Infect Public Health; 2012 Mar; 5(1):35-42. PubMed ID: 22341841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
    Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
    Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
    Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
    Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
    Chaiyakunapruk N; Veenstra DL; Lipsky BA; Saint S
    Ann Intern Med; 2002 Jun; 136(11):792-801. PubMed ID: 12044127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Eur Surg Res; 2009; 43(3):286-90. PubMed ID: 19648751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
    Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
    Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
    Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention.
    Young EM; Commiskey ML; Wilson SJ
    Am J Infect Control; 2006 Oct; 34(8):503-6. PubMed ID: 17015155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates.
    Garland JS; Alex CP; Uhing MR; Peterside IE; Rentz A; Harris MC
    J Perinatol; 2009 Dec; 29(12):808-13. PubMed ID: 19812587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous catheter infection in adults in acute hospital settings.
    Jones CA
    Br J Nurs; 2006 Apr 13-26; 15(7):362, 364-8. PubMed ID: 16723935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin antiseptics used prior to intravascular catheter insertion.
    Adams D; Elliot TS
    Br J Nurs; 2007 Mar 8-21; 16(5):278-80. PubMed ID: 17505372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
    Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
    Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous catheter-related bloodstream infections: improving post-insertion catheter care.
    Shapey IM; Foster MA; Whitehouse T; Jumaa P; Bion JF
    J Hosp Infect; 2009 Feb; 71(2):117-22. PubMed ID: 19013680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
    Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
    J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.